NovoCure Ltd (NASDAQ: NVCR) stock closed at $19.69 on 11/27/24 after a major increase of 10.1%. This advance was accompanied by normal trading volume. The stock has risen 19.5% during the last week and has been strong relative to the market over the last nine months.
Current PriceTarget Research Rating
NovoCure has a current Value Trend Rating of D (Negative). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing inconsistent signals. NovoCure has a very low Appreciation Score of 10 but a neutral Power Rating of 53, triggering the Negative Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment